DeOndra Dixon INCLUDE Project Act of 2025
Summary
HR3491 (DeOndra Dixon INCLUDE Project Act) authorizes a Down syndrome research program at NIH but appropriates zero funding. With only 5 procedural actions over a year and stalled committee markup, the bill has no near-term market impact. No public companies are directly affected.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.Zero appropriated funds — authorization-only bill has no direct financial impact on companies
- 2.Stalled legislative velocity: 1-year gap between introduction and committee markup
- 3.No public companies named or financially linked; academic research institutions are the sole beneficiaries if funding materializes
Market Implications
No publicly traded companies have direct revenue exposure to this authorization-only bill. The research program would benefit academic grantees, not corporate entities. Investors should not adjust positions based on this legislation.
Full Analysis
The bill, introduced May 2025, authorizes the NIH Director to carry out the INCLUDE Project for Down syndrome research. Its status remains 'Reported out of committee — awaiting floor action' after a unanimous 46-0 committee vote on May 21, 2026. However, the bill explicitly does not appropriate any funds — it merely authorizes a program structure. No dollar amounts appear in the text, and the action history shows nearly a year elapsed between introduction and the single committee markup, indicating low legislative priority. Authorizations without appropriations have no binding effect on federal spending or private sector revenue. The research program, if eventually funded through separate appropriations, would flow through NIH grants to academic institutions and research hospitals, not directly to publicly traded companies. No pharmaceutical, biotech, or diagnostic company is named in the bill or its findings. Related bills (S891, HR1768) cover broader healthcare topics but lack specific Down syndrome funding mechanisms. With no market catalyst, no funding stream, and no named corporate beneficiaries, this bill registers as procedural noise for investors.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
Multiple independent sources confirm this signal’s market thesis
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
MERCK SHARP & DOHME LLC: $2.4B Department of Health and Human Services Contract Vehicle
PA DEPARTMENT OF HUMAN SERVICES: $1.0B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $1.5B Department of Homeland Security Grant
HUMAN SERVICES, NEW JERSEY DEPARTMENT OF: $16.9B Department of Health and Human Services Grant
STATE OF FLORIDA DIVISION OF EMERGENCY MANAGEMENT: $2.9B Department of Homeland Security Grant
GOVERNOR'S AUTHORIZED REPRESENTATIVE: $1.8B Department of Homeland Security Grant
DEPARTMENT OF SOCIAL SERVICES MISSO: $15.1B Department of Health and Human Services Grant
MINNESOTA DEPARTMENT OF HUMAN SERVICES: $14.1B Department of Health and Human Services Grant
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Regulatory Relief for Certain Stationary Sources to Promote American Chemical Manufacturing Security
President Trump issued a proclamation exempting certain chemical manufacturing facilities from compliance with the EPA's HON Rule for two years, citing unavailability of required technology and national security concerns. The exemption delays emissions-control deadlines and maintains pre-HON Rule standards for listed stationary sources, invoking authority under Clean Air Act section 112(i)(4).
Advancing Regenerative Agriculture and Strengthening American Farm Resilience
This executive order directs the EPA, USDA, and HHS to prioritize registration of alternative pesticides, expedite cumulative exposure research, and maximize funding for a regenerative agriculture pilot program, while creating public-private partnerships to expand adoption of conservation farming practices. The order specifically instructs the EPA Administrator to speed up registration actions for substances that can replace older active ingredients, and requires HHS to issue a grand prize challenge for cumulative chemical exposure evaluation technologies.
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Free — no credit card
Get the next market-moving signal before the news does
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →